Efficacy of 3D-Printed Mouth Splints

Description

The study will investigate the effectiveness of a 3D-printed mouth splint designed to increase dimensions of oral aperture and reduce disability associated with mouth contractures. The validated Mouth Impairment and Disability Assessment (MIDA) survey will be used to objectively measure patient progress in functionality and quality of life.

Conditions

Microstomia

Talk to us

Study Overview

On this page

Study Details

Study overview

The study will investigate the effectiveness of a 3D-printed mouth splint designed to increase dimensions of oral aperture and reduce disability associated with mouth contractures. The validated Mouth Impairment and Disability Assessment (MIDA) survey will be used to objectively measure patient progress in functionality and quality of life.

Efficacy of 3D-Printed Mouth Splints in the Management of Microstomia in Burn Patients

Efficacy of 3D-Printed Mouth Splints

Condition
Microstomia
Intervention / Treatment

-

Contacts and Locations

Winston-Salem

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States, 27157

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients 2 years to 99 years of age with documented microstomia following burn injuries.
  • * Ability to comply with prescribed home exercises and follow-up visits.
  • * Cognitive or physical inability to perform the prescribed exercises.
  • * Inability of a caretaker to be able to deliver therapy daily.
  • * Concomitant conditions that may significantly affect oral aperture (e.g., temporomandibular joint (TMJ) disorders).

Ages Eligible for Study

2 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Christopher Runyan, MD, PhD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

2025-12